During psoriasis development, the increased expression of inflammatory cytokines, such as tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-17A, and IL-22 triggers uncontrolled inflammatory states and activates keratinocyte hyperproliferation [3,4]. This evidence concerns the gene IL22 and psoriasis.